Welcome to the 3rd Spatial Biology for Drug Development Summit!
This year's forum unites key players from AbbVie, AstraZeneca, Amgen, Genentech, Daiichi Sankyo, Johnson & Johnson, and more, to catalyze the discovery and development of more effective therapeutics across numerous disease areas.
This is your opportunity to gain actionable insights and takeaways across 2-days to take a deep dive into spatial biology case studies across the entire drug discovery and development chain.
Full pricing and registration details for our *FREE to attend passes, eligibility criteria and more are available within the brochure.
Download the Full Event Guide to Discover:
18+ Expert Speakers delivering high-impact insights, practical experience and future-focused perspectives.
14+ Case Studies showcasing fresh data and proven strategies to help you maximise the value of spatial biology across your pipeline.
8+ Hours of Dedicated Networking giving you ample time to connect with peers, benchmark progress, and spark new collaborations.
4+ Panel & Discussion Sessions providing open forums to tackle practical challenges, share diverse viewpoints, and define clear actions for scaling spatial biology in drug development.
Companies on the Program:
Hear From Your Peers:
“The value of this meeting lies in the focused, cross-sector discussions that drive new ideas, challenge assumptions, and connect science to real-world needs. It’s a chance to engage directly with thought leaders, stay current, and help shape the direction of the field.”
Director - Mental Health, Neuroscience, FNIH